American Society of Hypertension
Given the ever increasing prevalence of hypertension in the United States
and the issues involved in treating cases of resistant and complex hypertension,
the Leadership of the American Society of Hypertension, Inc. (ASH) recognizes
that hypertension can no longer be considered as a single disease entity.
While hypertension is the most prevalent cause of stroke and kidney failure,
hypertension must be recognized as part of a bigger disease conglomerate
almost always accompanied by obesity, diabetes, kidney disease or many
other co-existing problems involving lifestyle and/or genetics.
Established in 1985 the American Society of Hypertension, Inc. (ASH) serves
as a professional forum for the exchange of information among basic scientists,
clinical investigators and health care clinicians—physician specialists,
primary care physicians, physician assistants, nurse practitioners and
PharmDs-- involved in the study or management of high blood pressure.
As the premier U.S. hypertension organization, ASH is committed to the
advancement of science, prevention and treatment of high blood pressure
and its cardio-renal consequences--including obesity and diabetes--especially
resistant and complex hypertension.
The Society remains committed to eliminating hypertension and its consequences
through a renewed and vigorous focus on translational research leading
to effective treatment strategies for patients.